⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | LIC MF Small Cap Fund - Regular Plan - Growth | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | LIC MF | HDFC MF |
| Category | Equity - Small cap Fund | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹32.62 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★★ | ★★★★★ |
| Benchmark | Nifty Smallcap 250 - TRI | BSE Health Care - TRI |
| Fund Manager | Sudhanshu Asthana | Nikhil Mathur |
| Inception | 21 Jun 2017 | 04 Oct 2023 |
| Returns | ||
| 1Y | 7.46% | 22.64% |
| 3Y | 15.14% | 30.41% |
| 5Y | 14.73% | — |
| Since Inception | 13.62% | 29.15% |
| Risk | ||
| 20.58 | 14.07 | |
| 0.98 | 0.59 | |
| 0.54 | 1.59 | |
| 2.60 | 21.67 | |
| 0.98 | 3.48 | |
| -18.05% | -9.23% | |
| Costs | ||
| Expense Ratio | 2.65% | 1.03% |
| Exit Load | Nil upto 12% of units and 1% for remaining units on or before 12M, Nil after 12M | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹200 | ₹100 |
| Min Lumpsum | ₹5,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
LIC MF98%
HDFC MF98%
2.4%Only 2.4% of holdings by weight are common between LIC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingLIC MFHDFC MF
Neuland Laboratories Ltd.2.35%3.24%
Category context: Equity vs Equity. Open the full Screener →